Akeso says its closely watched drug improved patient survival in a lung cancer trial
Posted:
Akeso, a Chinese biotech with a drug positioned to rival Merck’s megablockbuster Keytruda, has reported for the first time that the therapy can improve patient survival.
Artificial Intelligence is no longer a future concept in healthcare — it is already reshaping how clinicians work, how patients are treated, and how health systems operate under pressure.
But while the excitement around AI continues to grow, the real…
For decades, hospitals were designed around buildings, departments, and paper-based processes.
But healthcare is changing rapidly.
Rising patient demand, workforce shortages, digital transformation, and the shift toward preventative and community-based care are forcing healthcare leaders to rethink what a hospital…
Attendees
Sponsors and Exhibitors
Contact us